Dr. Ralph DaCosta

Clinical & Commercial Advisory Board

Founder & CSO, Moleculight

Dr. Ralph DaCosta received his PhD from the Department of Medical Biophysics, University of Toronto. His graduate research focused on the development and pioneering clinical application of advanced optical molecular imaging technologies for endoscopic diagnosis of early gastrointestinal cancers.

This work contributed to major improvements in the accuracy of conventional diagnostic endoscopy. These continue to directly benefit endoscopic cancer screening strategies around the world. Dr. DaCosta is a Scientist, Princess Margaret Cancer Centre, University Health Network (UHN). He is developing a comprehensive research program at UHN that focuses on accelerating the translation of these “bioimaging” capabilities directly into clinical practice. He also is a member of the Radiation Medicine Program (Princess Margaret Cancer Centre) and the Spatio-Temporal Targeted and Amplification of Radiation Response (STTARR) Innovation Center at UHN.

Dr. DaCosta is one of Canada’s leading experts in the area of biophotonics. His ongoing contribution to the field of cancer imaging has been recognized by numerous awards and invited presentations at international meeting